In Congress: Zika, FDA, Fraudulent Joinder

Law360, New York (February 21, 2016, 8:25 PM ET) -- Congress returns from its one-week President’s Day recess this week. The president’s budget request for fiscal year 2017 remains a focus of committee activity this week. In floor activities, the Senate will consider the nomination of the U.S. Food and Drug Administration Commissioner, while the House will focus on a number of suspensions and a bill to address fraudulent joinder for the purpose of defeating diversity jurisdiction.



The Senate is schedule to return to legislative business on Monday, with a cloture vote expected on the nomination...

To view the full article, register now.